Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

NAActive, not recruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

May 25, 2023

Study Completion Date

December 31, 2027

Conditions
Aortic Aneurysm, Abdominal
Interventions
DEVICE

GORE® EXCLUDER® Conformable AAA Endoprosthesis

Endovascular Aneurysm repair (EVAR) is a minimally invasive procedure designed to exclude an aneurysmal segment of the aorta from blood circulation. The EVAR procedure involves delivery of a stent- graft compressed onto a catheter to an aneurysmal segment of the aorta from a remote access site, generally the femoral artery. Arterial access may be done by either percutaneous or cut-down technique.

Trial Locations (51)

10305

Staten Island University Hospital, Staten Island

11219

Maimonides Medical Center, Brooklyn

14203

Research Foundation SUNY Buffalo, Buffalo

15232

University of Pittsburgh Medical Center, Pittsburgh

22031

Inova Cardiology-Fairfax, Virginia Beach

22908

University of Virginia, Charlottesville

23507

Sentara Medical Group, Norfolk

25304

CAMC Health Education and Research Institute, Inc., Charleston

27405

Moses Cone Memorial Hospital, Greensboro

27607

NC Heart and Vascular Research, LLC, Raleigh

27710

Duke University Medical Center, Durham

28801

Mission Hospital, Asheville

29401

Medical University of South Carolina, Charleston

29615

Prisma Health-Upstate, Greenville

30060

Vascular Surgical Associates, PC, Marietta

30342

Emory University, Atlanta

32207

River City Clinical Research, Jacksonville

32803

Florida Hospital, Orlando

33176

Baptist Cardiac and Vascular Institute, Miami

Washington University School of Medicine - St. Louis, St Louis

34232

Sarasota Vascular Specialists, Sarasota

35233

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University Medical Center, Nashville

37920

University of Tennessee, Knoxville

43214

Ohio Health Research Institute, Columbus

44195

Cleveland Clinic Foundation, Cleveland

45220

Good Samaritan Hospital-Cincinnati, Cincinnati

48109

University of Michigan, Ann Arbor

49546

Spectrum Health System, Grand Rapids

52242

University of Iowa Hospitals & Clinic, Iowa City

53215

Aurora Health Care, Metro Inc., Milwaukee

55407

Minneapolis Heart Institute Foundation - Abbott Northwestern Hospital, Minneapolis

55441

Minneapolis Radiology and Vascular Research Foundation, Plymouth

55805

Essentia Institute of Rural Health, Duluth

55905

Mayo Clinic - Rochester, Rochester

57105

Sanford Clinic - Clinic Research, Sioux Falls

57108

North Central Heart Institute, Ltd., Sioux Falls

57392

University of Wisconsin System, Madison

60153

Loyola University - Chicago, Maywood

62794

Southern Illinois University, Springfield

63110

Mercy Research, St Louis

70121

Ochsner Clinic Foundation, New Orleans

73120

Oklahoma Heart Hospital Research Foundation, Oklahoma City

77030

Texas Heart Institute/Baylor St. Luke's Medical Center, Houston

The Methodist Hospital - Houston, Houston

85054

Mayo Clinic Arizona, Phoenix

90033

University of Southern California, Los Angeles

94305

Leland Stanford Junior University, Stanford

03756

The Hitchcock Foundation, Lebanon

07960

AHA Hospital Corp., Morristown

02905

Rhode Island Hospital, Providence

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT02489539 - Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms | Biotech Hunter | Biotech Hunter